First described by its namesake British scientist in 1817, for 10 points, identify this disease characterized by tremors and slowness of movement, also called the "shaking palsy."
Earlier surgical treatments for this conditions involved pallidotomy and thalamotomy, while newer treatments for it can be supplemented by drugs which inhibit monoamine oxidase-B. It is caused by the degeneration of the neurons of the substantia nigra, which decreases the production of dopamine, and L-dopa is most commonly used to treat its symptoms. First described by its namesake British scientist in 1817, for 10 points, identify this disease characterized by tremors and slowness of movement, also called the "shaking palsy."
Earlier surgical treatments for this conditions involved pallidotomy and thalamotomy, while newer treatments for it can be supplemented by drugs which inhibit monoamine oxidase-B.
Parkinson's disease